Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Frenkel

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Environmental Health Perspectives|May 1, 1989
Oxidation of DNA bases by tumor promoter-activated processesK Frenkel
Pharmacology & Therapeutics|January 1, 1992
Carcinogen-mediated oxidant formation and oxidative DNA damageK Frenkel
JAMA|August 3, 1994
Ocular toxoplasmosisJ K Frenkel
Neurology|September 1, 1975
Letter: Sulfisoxazole called suboptimal therapy in toxoplasmosisJ K Frenkel
Federation Proceedings|May 15, 1978
Immune responses to nonviral intracellular infections of hamstersJ K Frenkel
Science (New York, N.Y.)|March 27, 2010
Reflection on the mechanism of action of chemotherapeutic drugsJ K FRENKEL
Journal of the American Veterinary Medical Association|January 15, 1990
Transmission of toxoplasmosis and the role of immunity in limiting transmission and illnessJ K Frenkel
The Journal of Parasitology|December 1, 1981
False-negative serologic tests for Toxoplasma in birdsJ K Frenkel
The Journal of Infectious Diseases|December 1, 1970
Pursuing toxoplasmaJ K Frenkel
Bulletin of the New York Academy of Medicine|February 1, 1974
Breaking the transmission chain of Toxoplasma: a program for the prevention of human toxoplasmosisJ K Frenkel
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Environmental Health Perspectives|May 1, 1989
Oxidation of DNA bases by tumor promoter-activated processesK Frenkel
Pharmacology & Therapeutics|January 1, 1992
Carcinogen-mediated oxidant formation and oxidative DNA damageK Frenkel
JAMA|August 3, 1994
Ocular toxoplasmosisJ K Frenkel
Neurology|September 1, 1975
Letter: Sulfisoxazole called suboptimal therapy in toxoplasmosisJ K Frenkel
Federation Proceedings|May 15, 1978
Immune responses to nonviral intracellular infections of hamstersJ K Frenkel
Science (New York, N.Y.)|March 27, 2010
Reflection on the mechanism of action of chemotherapeutic drugsJ K FRENKEL
Journal of the American Veterinary Medical Association|January 15, 1990
Transmission of toxoplasmosis and the role of immunity in limiting transmission and illnessJ K Frenkel
The Journal of Parasitology|December 1, 1981
False-negative serologic tests for Toxoplasma in birdsJ K Frenkel
The Journal of Infectious Diseases|December 1, 1970
Pursuing toxoplasmaJ K Frenkel
Bulletin of the New York Academy of Medicine|February 1, 1974
Breaking the transmission chain of Toxoplasma: a program for the prevention of human toxoplasmosisJ K Frenkel
Pageof 21